RISEDRONATE SODIUM
Substance profile for UNII OFG5EXG60L, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#
- UNII
- OFG5EXG60L
- Preferred term
- RISEDRONATE SODIUM
- Registry number
- 115436-72-1
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- C7H10NO7P2.Na

Chemical And Database Identifiers#
- InChIKey
- DRFDPXKCEWYIAW-UHFFFAOYSA-M
- SMILES
- [Na+].OC(CC1=CN=CC=C1)(P(O)(O)=O)P(O)([O-])=O
- RxCUI
- 60334
- PubChem
- 0
- NCIt
- C1528
- INN ID
- 0
Open Chemistry Sources#
| Source | Identifier | Link |
|---|---|---|
| PubChem InChIKey Search | DRFDPXKCEWYIAW-UHFFFAOYSA-M | |
| RxNorm | 60334 | |
| NCI Thesaurus | C1528 | |
| FDA Substance Registration System | OFG5EXG60L |
DailyMed Socrata Ingredients#
| Ingredient | DailyMed label | SPL version |
|---|---|---|
| RISEDRONATE SODIUM | These highlights do not include all the information needed to use ACTONEL safely and effectively. See full prescribing information for ACTONEL. ACTONEL ® (risedronate sodium) tablets Initial U.S. Approval: 1998 | 10 |
| RISEDRONATE SODIUM | These highlights do not include all the information needed to use ACTONEL safely and effectively. See full prescribing information for ACTONEL. ACTONEL ® (risedronate sodium) tablets Initial U.S. Approval: 1998 | 2 |
| RISEDRONATE SODIUM ANHYDROUS | RISEDRONATE SODIUM TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.] | 9 |
| RISEDRONATE SODIUM ANHYDROUS | RISEDRONATE SODIUM TABLET, FILM COATED [APOTEX CORP.] | 4 |